Biology and Targetability of the Extended Spectrum of PIK3CA Mutations Detected in Breast Carcinoma

Overview of attention for article published in Clinical Cancer Research, November 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

So far, Altmetric has seen 28 X posts from 24 X users, with an upper bound of 56,671 followers.

RT @CCR_AACR: Extended spectrum of PIK3CA mutations in breast cancer. https://t.co/vnrHeNvTyF https://t.co/N0IPE0gDM1

うーん、関係者にはややこしい案件 20230315 CCR PI3K阻害剤アルペリシブ、承認元になったSOLAR-1試験で対象としていたホットスポット7,9,20の変異以外(全体の20%)においても、PFS延長を示しているとのこと。いやはやなんとも。 https://t.co/K5t0S8AUi2

RT @CCR_AACR: Extended spectrum of PIK3CA mutations in breast cancer. https://t.co/vnrHeNvTyF https://t.co/N0IPE0gDM1

Extended spectrum of PIK3CA mutations in breast cancer. https://t.co/vnrHeNvTyF https://t.co/N0IPE0gDM1

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 24 additional X posts.